EUCTR2012-000904-14-AT进行中（未招募）不适用
PHARMACOKINETICS OF MICAFUNGIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION - MICA_HDF
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 19 to 70 years
- •Suspected or proven candia infection requiring parenteral antifungal therapy
- •Continuous venovenous hemofiltration because of an acute renal failure
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 6
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 4
排除标准
- •Known history of hypersensitivity to echinocandins.
- •An expected survival of less than three days.
- •Known alcohol dependency, epilepsy, pregnancy or liver failure.
- •Sooroesophagitis
研究者
相似试验
招募中
不适用
Study of clinical pharmacokinetics of Micafungin in patients with extensive burextensive burnJPRN-UMIN000004815Division of Emergency Medicine10
进行中（未招募）
1 期
Exposure to micafungin given twice/week compared to once/day.prophylaxis for patients at high risk for invasive fungal diseasesMedDRA version: 17.0Level: PTClassification code 10017533Term: Fungal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2013-002848-93-BERadboud University Medical Centre20
进行中（未招募）
1 期
Exposure to micafungin given twice/week compared to once/day.prophylaxis for patients at high risk for invasive fungal diseasesMedDRA version: 14.1 Level: PT Classification code 10017533 Term: Fungal infection System Organ Class: 10021881 - Infections and infestationsEUCTR2013-002848-93-NLRadboud University Medical Centre30
已完成
4 期
Micafungin (Mycamine®) pharmacokinetics given as a single intravenous dose to obese patients (MICADO).NL-OMON43057Radboud Universitair Medisch Centrum24
已完成
4 期
Pharmacokinetics of Micafungin During Continuous Venovenous HemofiltrationCandida SepsisNCT02651038Medical University of Vienna10